Search Result "mirapex"
The Effects of Speech Therapy and Pharmacological Treatments on Voice and Speech in Parkinsons Disease: A Review of the Literature
Journal: Current Medicinal Chemistry
Volume: 9 Issue: 1 Year: 2002 Page: 1359-1366
Author(s): Geralyn M. Schulz
Parkinson Disease and Antiparkinsonian Drugs
Ebook: Medicinal Chemistry for Pharmacy Students
Volume: 2 Year: 2020
Author(s): Ashok E. Philip,George DeMaagd,M. O. Faruk Khan
Doi: 10.2174/9789811454073120020010
Computational Models of Neuronal Biophysics and the Characterization of Potential Neuropharmacological Targets
Journal: Current Medicinal Chemistry
Volume: 15 Issue: 2 Year: 2008 Page: 2456-2471
Author(s): Michele Ferrante, Kim T. Blackwell, Michele Migliore, Giorgio A. Ascoli
The Dopamine D2 and Adenosine A2A Receptors: Past, Present and Future Trends for the Treatment of Parkinson's Disease
Journal: Current Medicinal Chemistry
Volume: 21 Issue: 27 Year: 2014 Page: 3188-3210
Author(s): M. Jorg,P.J. Scammells,B. Capuano
Recent Advances in Mass Spectrometry for the Identification of Neurochemicals and their Metabolites in Biofluids
Journal: Current Neuropharmacology
Volume: 11 Issue: 4 Year: 2013 Page: 436-464
Author(s): Suresh Kumar Kailasa,Hui-Fen Wu
Iron Chelators as Potential Therapeutic Agents for Parkinsons Disease
Journal: Current Bioactive Compounds
Volume: 4 Issue: 3 Year: 2008 Page: 150-158
Author(s): Carlos A. Perez, Yong Tong, Maolin Guo
Drugs Used to Treat Parkinsons Disease, Present Status and Future Directions
Journal: CNS & Neurological Disorders - Drug Targets
Volume: 7 Issue: 4 Year: 2008 Page: 321-342
Author(s): Omar M.E. Abdel-Salam
Clinical Trials for Neuroprotection in ALS
Journal: CNS & Neurological Disorders - Drug Targets
Volume: 9 Issue: 3 Year: 2010 Page: 305-313
Author(s): G. Siciliano, C. Carlesi, L. Pasquali, S. Piazza, S. Pietracupa, F. Fornai, S. Ruggieri, L. Murri
Current Drugs and Potential Future Neuroprotective Compounds for Parkinsonâs Disease
Journal: Current Neuropharmacology
Volume: 17 Issue: 3 Year: 2019 Page: 295-306
Author(s): Iván Carrera,Ramón Cacabelos
D2 Receptor Partial Agonists: Treatment of CNS Disorders of Dopamine Function
Journal: Current Topics in Medicinal Chemistry
Volume: 8 Issue: 1 Year: 2008 Page: 1068-1088
Author(s): John H. Kehne, Terrance H. Andree, Julia N. Heinrich